Auna S.A. (NYSE:AUNA – Get Free Report)’s stock price traded up 0.1% during trading on Thursday . The company traded as high as $5.27 and last traded at $5.2050. 161,583 shares traded hands during trading, an increase of 18% from the average session volume of 136,836 shares. The stock had previously closed at $5.20.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on AUNA shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 5th. Finally, JPMorgan Chase & Co. reduced their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $6.97.
Read Our Latest Stock Report on AUNA
Auna Stock Up 0.1%
Auna (NYSE:AUNA – Get Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.14). Auna had a return on equity of 16.25% and a net margin of 1.53%.The firm had revenue of $336.84 million for the quarter, compared to the consensus estimate of $320.54 million. Equities analysts expect that Auna S.A. will post 0.81 earnings per share for the current fiscal year.
Insider Buying and Selling at Auna
In other Auna news, President Leon Jesus Zamora acquired 30,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was purchased at an average price of $4.39 per share, for a total transaction of $131,700.00. Following the acquisition, the president owned 45,914 shares in the company, valued at approximately $201,562.46. This trade represents a 188.51% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John Wilton sold 17,574 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the sale, the director owned 49,974 shares of the company’s stock, valued at approximately $208,391.58. This represents a 26.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders acquired 83,454 shares of company stock worth $357,063 over the last ninety days.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC increased its position in Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after buying an additional 554,707 shares in the last quarter. Marshall Wace LLP raised its stake in Auna by 391.0% in the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock valued at $802,000 after buying an additional 129,799 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in Auna in the first quarter worth about $557,000. Goldman Sachs Group Inc. boosted its holdings in Auna by 43.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock worth $352,000 after acquiring an additional 21,579 shares in the last quarter. Finally, Hsbc Holdings PLC purchased a new stake in shares of Auna during the first quarter worth about $324,000.
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Recommended Stories
- Five stocks we like better than Auna
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
